[go: up one dir, main page]

UA95830U - Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome - Google Patents

Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome

Info

Publication number
UA95830U
UA95830U UAU201407619U UAU201407619U UA95830U UA 95830 U UA95830 U UA 95830U UA U201407619 U UAU201407619 U UA U201407619U UA U201407619 U UAU201407619 U UA U201407619U UA 95830 U UA95830 U UA 95830U
Authority
UA
Ukraine
Prior art keywords
pulmonary disease
chronic obstructive
obstructive pulmonary
metabolic syndrome
disease associated
Prior art date
Application number
UAU201407619U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Ганна Ярославівна Ступницька
Олександр Іванович Федів
Original Assignee
Буковинський Державний Медичний Університет Моз України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Буковинський Державний Медичний Університет Моз України filed Critical Буковинський Державний Медичний Університет Моз України
Priority to UAU201407619U priority Critical patent/UA95830U/en
Publication of UA95830U publication Critical patent/UA95830U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for treating chronic obstructive pulmonary disease associated with metabolic syndrome by basic therapy. It is additionally prescribed to administer S(-)amlodipine besylate at a dose of 2.5 mg and atorvastatin calcium at a dose of 10 mg, as a combined preparation "Amlostat" (Kusum Pharm, Ukraine), for six months.
UAU201407619U 2014-07-07 2014-07-07 Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome UA95830U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201407619U UA95830U (en) 2014-07-07 2014-07-07 Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201407619U UA95830U (en) 2014-07-07 2014-07-07 Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome

Publications (1)

Publication Number Publication Date
UA95830U true UA95830U (en) 2015-01-12

Family

ID=52988739

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201407619U UA95830U (en) 2014-07-07 2014-07-07 Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome

Country Status (1)

Country Link
UA (1) UA95830U (en)

Similar Documents

Publication Publication Date Title
JP2012193216A5 (en)
EA201591290A2 (en) CRENOLOLIBS FOR THE TREATMENT OF PROLIFERATIVE DISORDERS RELATED TO FLT3 MUTATION
EA201491060A1 (en) NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
JOP20160092B1 (en) Treatment of beta thalassemia using a ligne tray
EA201500365A1 (en) COMBINATION OF REGORAPHENIBE AND ACETYLSALICYLIC ACID TO CURE CANCER
HK1221646A1 (en) Use of high dose pridopidine for treating huntington's disease
EA201490228A1 (en) NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE
EA201592250A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of diseases
ZA202105976B (en) Pharmaceutical dosage form for application to mucous membranes and methods for producing same
WO2012116176A3 (en) Asymmetric ureas and medical uses thereof
EA033054B1 (en) Glutarimide derivative, use thereof, pharmaceutical composition based thereon, methods for producing same
EA201691918A1 (en) PHARMACEUTICAL COMPOSITIONS OF KINAZ INHIBITOR KINAZ OF THE RAF FAMILY, METHODS OF THEIR PRODUCTION AND METHODS OF THEIR USE
EA201691789A1 (en) PHARMACEUTICAL COMPOSITIONS AND SALTS OF 1,2,4-OXADIAZOLBENZOIC ACID
MX381440B (en) PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ULCERATIVE COLITIS.
EA201691656A2 (en) THERAPEUTIC WAYS WITH THE USE OF NORIBOGOGINE AND RELATED COMPOUNDS
MY200278A (en) Methods of improving exercise capacity in fontan patients using udenafil compositions
MX2017012022A (en) Organic compounds.
WO2016122289A3 (en) Composition including verbenone derivative for preventing or alleviating side effects of reperfusion procedure
UA95830U (en) Method for treating chronic obstructive pulmonary disease associated with metabolic syndrome
MX2014014817A (en) Compounds for treating inflammation and pain.
TW201613600A (en) Piperazinyl derivative reduces HFD-induced accumulation of fat in the liver, therapeutically
TW201613606A (en) Therapeutic drug for chronic renal failure
EA201790140A1 (en) PHARMACEUTICAL MEDICINE FORMS
EA201592261A1 (en) PHARMACEUTICAL COMPOSITIONS, INCLUDING AGOMELATIN IN THE FORM OF HOMELATIN CRYSTALS WITH ORGANIC ACID
PH12015502560A1 (en) Use of a thiazolo pyrimidinone for the treatment of inflammatory bowel disease